Agnogenic myeloid metaplasia in children

Area of Science:

• Hematology
• Pediatric Oncology
• Genetics

Background:

• Agnogenic myeloid metaplasia (AMM) is a chronic myeloproliferative neoplasm typically affecting adults.
• Pediatric cases of AMM are exceedingly rare, with most childhood myelofibrosis presenting as an acute, rapidly fatal condition.
• AMM is characterized by bone marrow fibrosis, splenomegaly, extramedullary hematopoiesis, and abnormal red blood cell morphology.

Observation:

• Three infants, aged 9, 10, and 16 months, presented with symptoms consistent with AMM.
• Two of the affected infants were siblings, indicating a potential familial predisposition.
• Clinical and laboratory findings aligned with the diagnostic criteria for agnogenic myeloid metaplasia.

Findings:

• The presentation of AMM in these young children challenges the notion that it is exclusively an adult disease.
• The occurrence in siblings strongly suggests a genetic component, potentially an autosomal recessive inheritance pattern.
• Morphological examination of red blood cells in these cases may reveal characteristic abnormalities, contrasting with typical pediatric myelofibrosis.

Implications:

• This case series expands the known age range for agnogenic myeloid metaplasia.
• The findings necessitate further research into the genetic underpinnings of AMM, particularly in pediatric populations.
• Early identification and genetic counseling may become crucial for families with a history of myeloproliferative neoplasms.